Array BioPharma announces strategic collaboration with Merck

Array BioPharma announces strategic collaboration with Merck

BOULDER -- Array BioPharma Inc .(Nasdaq: ARRY) announced it has entered into a clinical trial collaboration agreement with Merck (known as MSD outsidethe United StatesandCanada) to investigate... Read More

Tuesday May 9, 2017 0 comments Tags: Boulder, Array BioPharma, Merck, Ron Squarer, binimetinib, KEYTRUDA